Carta al Editor
Anemia y eosinofilia secundaria a Strongyloides en un paciente tratado con anti-TNF alfa
Anaemia and Eosinophilia Secondary to Strongyloides in a Patient Treated with Anti-TNF-Alpha
Leído
7864
Vecesse ha leído el artículo
1840
Total PDF
6024
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 5 | 21 | 26 |
| 2025 5 | 148 | 41 | 189 |
| 2025 4 | 170 | 33 | 203 |
| 2025 3 | 139 | 43 | 182 |
| 2025 2 | 164 | 32 | 196 |
| 2025 1 | 139 | 52 | 191 |
| 2024 12 | 107 | 45 | 152 |
| 2024 11 | 152 | 59 | 211 |
| 2024 10 | 146 | 26 | 172 |
| 2024 9 | 122 | 34 | 156 |
| 2024 8 | 135 | 38 | 173 |
| 2024 7 | 124 | 30 | 154 |
| 2024 6 | 141 | 44 | 185 |
| 2024 5 | 127 | 44 | 171 |
| 2024 4 | 114 | 29 | 143 |
| 2024 3 | 99 | 35 | 134 |
| 2024 2 | 74 | 24 | 98 |
| 2024 1 | 115 | 23 | 138 |
| 2023 12 | 115 | 22 | 137 |
| 2023 11 | 130 | 36 | 166 |
| 2023 10 | 131 | 29 | 160 |
| 2023 9 | 125 | 35 | 160 |
| 2023 8 | 81 | 11 | 92 |
| 2023 7 | 112 | 28 | 140 |
| 2023 6 | 130 | 24 | 154 |
| 2023 5 | 120 | 29 | 149 |
| 2023 4 | 97 | 17 | 114 |
| 2023 3 | 144 | 31 | 175 |
| 2023 2 | 144 | 28 | 172 |
| 2022 1 | 146 | 18 | 164 |
| 2022 12 | 137 | 34 | 171 |
| 2022 11 | 166 | 34 | 200 |
| 2022 10 | 143 | 36 | 179 |
| 2022 9 | 163 | 35 | 198 |
| 2022 8 | 130 | 35 | 165 |
| 2022 7 | 154 | 51 | 205 |
| 2022 6 | 151 | 43 | 194 |
| 2022 5 | 144 | 37 | 181 |
| 2022 4 | 131 | 63 | 194 |
| 2022 3 | 128 | 75 | 203 |
| 2022 2 | 112 | 41 | 153 |
| 2021 1 | 126 | 50 | 176 |
| 2021 12 | 110 | 36 | 146 |
| 2021 11 | 107 | 61 | 168 |
| 2021 10 | 106 | 63 | 169 |
| 2021 9 | 78 | 42 | 120 |
| 2021 8 | 52 | 30 | 82 |
| 2021 7 | 50 | 22 | 72 |
| 2021 6 | 56 | 34 | 90 |
| 2021 5 | 56 | 42 | 98 |
| 2021 2 | 1 | 0 | 1 |
| 2020 1 | 1 | 0 | 1 |
| 2020 12 | 4 | 2 | 6 |
| 2020 11 | 6 | 2 | 8 |
| 2020 10 | 1 | 2 | 3 |
| 2020 8 | 2 | 0 | 2 |
| 2020 6 | 1 | 2 | 3 |
| 2020 1 | 4 | 2 | 6 |
| 2019 9 | 1 | 0 | 1 |
| 2019 6 | 2 | 1 | 3 |
| 2019 4 | 1 | 2 | 3 |
| 2019 2 | 1 | 2 | 3 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 1 | 0 | 1 |
Mostrar todo
